Skip to main content

Table 6 MRI Evaluation (Cross-Sectional Area and Tunnel Dimensions) - Missing/Contaminated Graft Subjects Excluded

From: Xenograft for anterior cruciate ligament reconstruction was associated with high graft processing infection

  1 Week   12 Months   24 Months
Allo Xeno p-value   Allo Xeno p-value   Allo Xeno p-value
CSAmax 74.1 ± 28.6 68.4 ± 21.2 0.403   106.9 ± 49.9 121.9 ± 70.4 0.529   92.0 ± 32.9 113.8 ± 51.9 0.036*
FT–AP 10.2 ± 1.3 9.9 ± 1.0 0.571   9.6 ± 1.7 13.6 ± 2.2 < 0.001**   10.2 ± 2.2 11.8 ± 2.6 0.122
FT–ML 10.0 ± 1.2 9.3 ± 0.8 0.096   11.2 ± 2.3 14.1 ± 3.2 0.011*   9.6 ± 2.0 13.1 ± 2.0 < 0.001**
TT–AP 9.7 ± 1.6 9.1 ± 2.2 0.095   10.3 ± 2.7 12.2 ± 1.8 < 0.001**   11.4 ± 2.5 13.3 ± 2.2 0.013*
TT–ML 9.4 ± 1.6 9.8 ± 1.7 0.339   10.3 ± 2.1 12.5 ± 2.1 < 0.001**   10.1 ± 2.0 12.1 ± 1.7 < 0.001**
  1. *p < 0.05; **p < 0.001; CSAmax, Maximum graft cross-sectional area in mm2;FT–AP, Femoral tunnel anterior-posterior in mm; FT–ML, Femoral tunnel medial-lateral in mm; TT–AP, Tibial tunnel anterior-posterior in mm; TT–ML, Tibial tunnel medial-lateral in mm